USDA-ARS Postdoctoral Research : Development of Novel Vaccines Poultry Viral Diseases

Organization

U.S. Department of Agriculture (USDA)

USDA-ARS-SEA-

11/20/2026 3:00:00 PM Eastern Time Zone

• Applications are reviewed on a rolling-basis.

A research opportunity is currently available with the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS), located in Athens, Georgia.

The Agricultural Research Service (ARS) is the U.S. Department of Agriculture's chief scientific in‑house research agency with a mission to find solutions to agricultural problems that affect Americans every day from field to table. ARS will deliver cutting‑edge, scientific tools and innovative solutions for American farmers, producers, industry, and communities to support the nourishment and well‑being of all people; sustain our nation’s agroecosystems and natural resources;

and ensure the economic competitiveness and excellence of our agriculture. The vision of the agency is to provide global leadership in agricultural discoveries through scientific excellence.

You will be part of the research team learning about developing recombinant Marek's disease virus vaccines to prevent both Marek's disease and other poultry diseases. The project involves the construction of recombinant vaccines using molecularly cloned Marek's disease virus as a vector platform and the evaluation of the efficacy against Marek's disease and targeted poultry disease. You will construct the recombinant Marek's disease virus that expresses the foreign antigens.

You will learn the construction of recombinant avian herpes virus vaccines, conduct vaccine efficacy studies to develop novel poultry vaccines, including sample collection from animals, execution of viral genome detection, and data analysis.

• Recovery of Infectious Avian Herpesviruses:
  You will learn the techniques required to recover infectious avian herpes viruses from DNA transfection processes, gaining a deeper understanding of molecular virology and virus recovery methods.
• Quantification of Virus Infectivity and Titer:
  You will be trained to accurately quantify virus infectivity and determine viral titers, developing expertise in virological assays and data interpretation.
• Modification of Cloned Virus Genome:
  You gain proficiency in using advanced recombineering technologies to modify cloned virus genomes, learning how to apply genetic engineering techniques for the study and manipulation of viral pathogens.
• Evaluation of Vaccinal Efficacy:
  You learn how to evaluate the vaccinal efficacy of Marek's disease virus vector vaccines, including experimental design, data collection, and analysis to assess vaccine performance and effectiveness.

Through these learning objectives, you will develop a robust skill set in virology, molecular biology, and vaccine development, contributing to advancements in avian disease prevention and control.

The mentor for this opportunity is Taejoong Kim (taejoong.kim). If you have questions about the nature of the research, please contact the mentor(s).

As soon as possible. Start date is flexible and will depend on a variety of factors.

The appointment will initially be for one year, but may be renewed upon recommendation of ARS and is contingent on the availability of funds.

The appointment is full time.

The participant will receive a monthly stipend commensurate with educational level and experience.

This opportunity is available to U.S. citizens only.

This program, administered by ORAU through its contract with the U.S. Department of Energy (DOE) to manage the Oak Ridge…